Recent blog posts
NPR2 Biologics Sequence Review Report 2026: Atrial natriuretic peptide receptor 2 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
NPR2 Biologics Sequence Review Report 2026: Atrial natriuretic peptide receptor 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of NPR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
NMBR Biologics Sequence Review Report 2026: Neuromedin-B receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
NMBR Biologics Sequence Review Report 2026: Neuromedin-B receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of NMBR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
NPBWR1 Biologics Sequence Review Report 2026: Neuropeptides B/W receptor type 1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
NPBWR1 Biologics Sequence Review Report 2026: Neuropeptides B/W receptor type 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of NPBWR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
NCR2 Biologics Sequence Review Report 2026: Natural cytotoxicity triggering receptor 2 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
NCR2 Biologics Sequence Review Report 2026: Natural cytotoxicity triggering receptor 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of NCR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
NCR1 Biologics Sequence Review Report 2026: Natural cytotoxicity triggering receptor 1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
NCR1 Biologics Sequence Review Report 2026: Natural cytotoxicity triggering receptor 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of NCR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MTNR1B Biologics Sequence Review Report 2026: Melatonin receptor type 1B Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MTNR1B Biologics Sequence Review Report 2026: Melatonin receptor type 1B Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of MTNR1B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MTNR1A Biologics Sequence Review Report 2026: Melatonin receptor type 1A Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MTNR1A Biologics Sequence Review Report 2026: Melatonin receptor type 1A Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of MTNR1A protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MPL Biologics Sequence Review Report 2026: Thrombopoietin receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MPL Biologics Sequence Review Report 2026: Thrombopoietin receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of MPL protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MPIG6B Biologics Sequence Review Report 2026: Megakaryocyte and platelet inhibitory receptor G6b Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MPIG6B Biologics Sequence Review Report 2026: Megakaryocyte and platelet inhibitory receptor G6b Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of MPIG6B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MSR1 Biologics Sequence Review Report 2026: Macrophage scavenger receptor types I and II Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MSR1 Biologics Sequence Review Report 2026: Macrophage scavenger receptor types I and II Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of MSR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MC5R Biologics Sequence Review Report 2026: Melanocortin receptor 5 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MC5R Biologics Sequence Review Report 2026: Melanocortin receptor 5 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of MC5R protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
LTK Biologics Sequence Review Report 2026: Leukocyte tyrosine kinase receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
LTK Biologics Sequence Review Report 2026: Leukocyte tyrosine kinase receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of LTK protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →